US/UK/Canada

Share

About Us

Phase Holographic Imaging (PHI) develops and markets instrumentation for non-invasive time-lapse imaging. The company’s HoloMonitor product line is used for long-term quantitative analysis of living cell cultures, particularly in preclinical research and regenerative medicine. PHI is based in Lund, Sweden and Boston, Massachusetts.

Contacts

  • Anders Månsson

    CEO


    Skiffervägen 48, 224 78, Lund
    http://www.phiab.com

    • Links

    Pick a time period -
    Tags ( Active)

    Half Year Report May-October 2015/16

    SUMMARY · Net sales and backorders amounted to 2.9 MSEK at reporting date (7 months). Net sales during 2014/15 amounted to 2.7 MSEK. · 5.2 MSEK in credit has been granted. The funds will be used to increase production capacity to secure the delivery of backorders, resulting in that revenues during 2015/16 are expected to increase relative to 2014/15. · Big Pharma company orders a 3rdmotorized HoloMonitor M4.5 unit in follow-up order. · Expansion into the pharmaceutical industry re-schedules implementation of fluorescence analysis. RESULT OF THE PERIOD Net sales

    Phase Holographic Imaging invited to speak at world leading scientific event

    Phase Holographic Imaging has been invited to give an invited talk in February at the world’s leading scientific event for biomedical optics, BiOS 2016 in San Francisco. For the second consecutive year BiOS hosts a conference exclusively dedicated to holographic microscopy and phase imaging. At the conference, applications of HoloMonitor® technology in academia and the pharmaceutical industry will be presented.“The size and length of the four day conference reflects the accelerating interest in holographic microscopy and its applications. It is an honor to be invited to speak about our

    Year-End Report May 1, 2014 – April 30, 2015

    4th quarter February – April Net sales                                                                                    559 (539) TSEK Operating result (EBIT)                                                  -2 544 (-1 950) TSEK Result before tax                                                            -2 572 (-2 009) TSEK Net result                                                                         -2 572 (-2 009) TSEK Earnings per share                                                                -0.26 (-0.39) SEK   Full year Net sales

    Germany’s largest biomedical research institute foster the use of Phase Holographic Imaging technology

    German Cancer Research Center (DKFZ) in Heidelberg and Phase Holographic Imaging have signed a collaboration agreement, to foster the use of HoloMonitor technology at DKFZ. A HoloMonitor M4 with a motorized XY-stage will be centrally installed at the Imaging and Cytometry Core Facility and made available to the over 1 000 cancer researchers at DKFZ.“DKFZ is one of the leading cancer research centers in Europe, if not the leading. Our strategy is to continue to demonstrate the benefits of HoloMonitor technology with leading research institutions and key opinion leaders on the forefront of

    Phase Holographic Imaging expands into Australia and respiratory research

    In April Phase Holographic Imaging (PHI) had outstanding orders of approximately 2 MSEK, consisting of 13 HoloMonitor M4 units and 15 orders for the recently launched motorized stage. A portion of these units have now been delivered. Among others, a HoloMonitor M4 with motorized stage has been delivered to one of the leading institutes for respiratory research in Australia – the Woolcock Institute of Medical Research.To improve the understanding of the mechanisms behind asthma the Respiratory Cellular and Molecular Biology Group will measure volume changes in respiratory muscle cells using

    There are no items matching the current filter
    There are no more items matching the current filter
    Back to top

    Subscribe

    Media